Dry-coated live viral vector vaccines delivered by nanopatch microprojections retain long-term thermostability and induce transgene-specific T cell responses in mice.

The disadvantages of needle-based immunisation motivate the development of simple, low cost, needle-free alternatives. Vaccine delivery to cutaneous environments rich in specialised antigen-presenting cells using microprojection patches has practical and immunological advantages over conventional ne...

Full description

Bibliographic Details
Main Authors: Frances E Pearson, Celia L McNeilly, Michael L Crichton, Clare A Primiero, Sally R Yukiko, Germain J P Fernando, Xianfeng Chen, Sarah C Gilbert, Adrian V S Hill, Mark A F Kendall
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23874462/?tool=EBI
_version_ 1818460868765024256
author Frances E Pearson
Celia L McNeilly
Michael L Crichton
Clare A Primiero
Sally R Yukiko
Germain J P Fernando
Xianfeng Chen
Sarah C Gilbert
Adrian V S Hill
Mark A F Kendall
author_facet Frances E Pearson
Celia L McNeilly
Michael L Crichton
Clare A Primiero
Sally R Yukiko
Germain J P Fernando
Xianfeng Chen
Sarah C Gilbert
Adrian V S Hill
Mark A F Kendall
author_sort Frances E Pearson
collection DOAJ
description The disadvantages of needle-based immunisation motivate the development of simple, low cost, needle-free alternatives. Vaccine delivery to cutaneous environments rich in specialised antigen-presenting cells using microprojection patches has practical and immunological advantages over conventional needle delivery. Additionally, stable coating of vaccine onto microprojections removes logistical obstacles presented by the strict requirement for cold-chain storage and distribution of liquid vaccine, or lyophilised vaccine plus diluent. These attributes make these technologies particularly suitable for delivery of vaccines against diseases such as malaria, which exerts its worst effects in countries with poorly-resourced healthcare systems. Live viral vectors including adenoviruses and poxviruses encoding exogenous antigens have shown significant clinical promise as vaccines, due to their ability to generate high numbers of antigen-specific T cells. Here, the simian adenovirus serotype 63 and the poxvirus modified vaccinia Ankara--two vectors under evaluation for the delivery of malaria antigens to humans--were formulated for coating onto Nanopatch microprojections and applied to murine skin. Co-formulation with the stabilising disaccharides trehalose and sucrose protected virions during the dry-coating process. Transgene-specific CD8(+) T cell responses following Nanopatch delivery of both vectors were similar to intradermal injection controls after a single immunisation (despite a much lower delivered dose), though MVA boosting of pre-primed responses with Nanopatch was found to be less effective than the ID route. Importantly, disaccharide-stabilised ChAd63 could be stored for 10 weeks at 37°C with less than 1 log10 loss of viability, and retained single-dose immunogenicity after storage. These data support the further development of microprojection patches for the deployment of live vaccines in hot climates.
first_indexed 2024-12-14T23:37:05Z
format Article
id doaj.art-939bada31aad4beab2f46dab10020487
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-14T23:37:05Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-939bada31aad4beab2f46dab100204872022-12-21T22:43:36ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0187e6788810.1371/journal.pone.0067888Dry-coated live viral vector vaccines delivered by nanopatch microprojections retain long-term thermostability and induce transgene-specific T cell responses in mice.Frances E PearsonCelia L McNeillyMichael L CrichtonClare A PrimieroSally R YukikoGermain J P FernandoXianfeng ChenSarah C GilbertAdrian V S HillMark A F KendallThe disadvantages of needle-based immunisation motivate the development of simple, low cost, needle-free alternatives. Vaccine delivery to cutaneous environments rich in specialised antigen-presenting cells using microprojection patches has practical and immunological advantages over conventional needle delivery. Additionally, stable coating of vaccine onto microprojections removes logistical obstacles presented by the strict requirement for cold-chain storage and distribution of liquid vaccine, or lyophilised vaccine plus diluent. These attributes make these technologies particularly suitable for delivery of vaccines against diseases such as malaria, which exerts its worst effects in countries with poorly-resourced healthcare systems. Live viral vectors including adenoviruses and poxviruses encoding exogenous antigens have shown significant clinical promise as vaccines, due to their ability to generate high numbers of antigen-specific T cells. Here, the simian adenovirus serotype 63 and the poxvirus modified vaccinia Ankara--two vectors under evaluation for the delivery of malaria antigens to humans--were formulated for coating onto Nanopatch microprojections and applied to murine skin. Co-formulation with the stabilising disaccharides trehalose and sucrose protected virions during the dry-coating process. Transgene-specific CD8(+) T cell responses following Nanopatch delivery of both vectors were similar to intradermal injection controls after a single immunisation (despite a much lower delivered dose), though MVA boosting of pre-primed responses with Nanopatch was found to be less effective than the ID route. Importantly, disaccharide-stabilised ChAd63 could be stored for 10 weeks at 37°C with less than 1 log10 loss of viability, and retained single-dose immunogenicity after storage. These data support the further development of microprojection patches for the deployment of live vaccines in hot climates.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23874462/?tool=EBI
spellingShingle Frances E Pearson
Celia L McNeilly
Michael L Crichton
Clare A Primiero
Sally R Yukiko
Germain J P Fernando
Xianfeng Chen
Sarah C Gilbert
Adrian V S Hill
Mark A F Kendall
Dry-coated live viral vector vaccines delivered by nanopatch microprojections retain long-term thermostability and induce transgene-specific T cell responses in mice.
PLoS ONE
title Dry-coated live viral vector vaccines delivered by nanopatch microprojections retain long-term thermostability and induce transgene-specific T cell responses in mice.
title_full Dry-coated live viral vector vaccines delivered by nanopatch microprojections retain long-term thermostability and induce transgene-specific T cell responses in mice.
title_fullStr Dry-coated live viral vector vaccines delivered by nanopatch microprojections retain long-term thermostability and induce transgene-specific T cell responses in mice.
title_full_unstemmed Dry-coated live viral vector vaccines delivered by nanopatch microprojections retain long-term thermostability and induce transgene-specific T cell responses in mice.
title_short Dry-coated live viral vector vaccines delivered by nanopatch microprojections retain long-term thermostability and induce transgene-specific T cell responses in mice.
title_sort dry coated live viral vector vaccines delivered by nanopatch microprojections retain long term thermostability and induce transgene specific t cell responses in mice
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23874462/?tool=EBI
work_keys_str_mv AT francesepearson drycoatedliveviralvectorvaccinesdeliveredbynanopatchmicroprojectionsretainlongtermthermostabilityandinducetransgenespecifictcellresponsesinmice
AT celialmcneilly drycoatedliveviralvectorvaccinesdeliveredbynanopatchmicroprojectionsretainlongtermthermostabilityandinducetransgenespecifictcellresponsesinmice
AT michaellcrichton drycoatedliveviralvectorvaccinesdeliveredbynanopatchmicroprojectionsretainlongtermthermostabilityandinducetransgenespecifictcellresponsesinmice
AT clareaprimiero drycoatedliveviralvectorvaccinesdeliveredbynanopatchmicroprojectionsretainlongtermthermostabilityandinducetransgenespecifictcellresponsesinmice
AT sallyryukiko drycoatedliveviralvectorvaccinesdeliveredbynanopatchmicroprojectionsretainlongtermthermostabilityandinducetransgenespecifictcellresponsesinmice
AT germainjpfernando drycoatedliveviralvectorvaccinesdeliveredbynanopatchmicroprojectionsretainlongtermthermostabilityandinducetransgenespecifictcellresponsesinmice
AT xianfengchen drycoatedliveviralvectorvaccinesdeliveredbynanopatchmicroprojectionsretainlongtermthermostabilityandinducetransgenespecifictcellresponsesinmice
AT sarahcgilbert drycoatedliveviralvectorvaccinesdeliveredbynanopatchmicroprojectionsretainlongtermthermostabilityandinducetransgenespecifictcellresponsesinmice
AT adrianvshill drycoatedliveviralvectorvaccinesdeliveredbynanopatchmicroprojectionsretainlongtermthermostabilityandinducetransgenespecifictcellresponsesinmice
AT markafkendall drycoatedliveviralvectorvaccinesdeliveredbynanopatchmicroprojectionsretainlongtermthermostabilityandinducetransgenespecifictcellresponsesinmice